Target intelligence / Profile preview

Norovirus major capsid protein VP1 (Viral Protein 1) (VP1)

Target
VP1
Molecular classification
Structural viral protein, Icosahedral capsid component, Non-enveloped virus capsid
01

Overview

Norovirus VP1 is the major structural protein of human norovirus, a non-enveloped icosahedral virus approximately 27 nm in diameter that causes acute gastroenteritis. The protein comprises 180 copies arranged as 90 dimers with T=3 icosahedral symmetry, organized into shell (S) and protruding (P) domains that establish the capsid architecture. The P2 subdomain, located at the virion surface, contains the binding pocket for histo-blood group antigens (HBGAs), which serve as cellular attachment factors essential for infection.[3][5] Recent structural analyses reveal that VP1 exhibits significant conformational flexibility, particularly in the P domain, which enables both receptor binding and immune evasion through antibody escape mechanisms.[3] While VP1 itself is not a traditional therapeutic target for direct inhibition, it represents an important focus for vaccine development and the identification of vulnerable epitopes that could be exploited for therapeutic interventions targeting norovirus infection.

Other names
Major capsid proteinCapsid protein VP1Shell protein (S domain)Protruding domain protein (P domain)
02

Mechanism of action

Not applicable (structural protein, not a therapeutic target)

03

Biological functions

Viral particle assembly and structure formationReceptor binding and cellular attachmentImmune evasion through epitope presentationViral genome encapsulation and protection
04

Disease associations

Norovirus infection (gastrointestinal disease)Human viral pathogenesis

Beyond the preview

Go deeper on Norovirus major capsid protein VP1 (Viral Protein 1) (VP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norovirus major capsid protein VP1 (Viral Protein 1) (VP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call